A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

Clinical trial NCT04659031 · COMPLETED

Trial details

NCT number: NCT04659031
Sponsor: Abcuro, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inclusion Body Myositis

Start date: 2021-05-25
Primary completion: 2025-01-10
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.